Professoriate Staff

Professor Xiang LIN
Assistant Professor,
Assistant Director (Knowledge Exchange & Technology Development),
School of Chinese Medicine, The University of Hong Kong
SPOKEN LANGUAGES

Cantonese, Mandarin and English

WRITTEN LANGUAGES

Chinese and English

ACADEMIC QUALIFICATION
Jan 2008 – May 2012 PhD, School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong
Sept 2003 – Jul 2007 Bachelor of Science, Department of Chinese Medicines, China Pharmaceutical University, Nanjing, China
CURRENT PROFESSIONAL SERVICES
2025 - Present Member, the Federation of Clinical Immunology Societies
2024 - Present Member, British Society for Immunology
2022 - Present Regular Member, The American Association of Immunologists
2021 - Present Affiliated Investigator, the State Key Laboratory of Pharmaceutical Biotechnology, the University of Hong Kong
2020 - 2022 Hon Secretary, Hong Kong Society of Flow Cytometry, Hong Kong
2015 - 2016 Assistant Secretary, Hong Kong Society for Immunology, Hong Kong
2014 - 2015 Hon Secretary, Hong Kong Society of Flow Cytometry, Hong Kong
WORK EXPERIENCE
Oct 2019 - Present Assistant Professor, School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong
Feb 2013 – Sept 2019 Post-doctoral Fellow, Department of Pathology, Li Ka Shing Faculty of Medicine, The University of Hong Kong
Jun 2012 – Jan 2013 Research Assistant, Department of Pathology, Li Ka Shing Faculty of Medicine, The University of Hong Kong
RESEARCH INTEREST AND ACHIEVEMENT

Research Grants

Nov 2025 – Nov 2027 Principal Investigator
The molecular mechanisms of Low-Dose Interleukin-2 in maintaining immunological homeostasis in patients with Sjögren's disease.
(International Science and Technology Cooperation Program (Hong Kong, Macao and Taiwan), on-going)
Oct 2025 – Oct 2028 Principal Investigator
7,3',4'-trihydroxyisoflavone targets the IL-6/c-Maf axis in regulating effector T cells in the treatment of Sjögren's disease.
(Shenzhen Natural Science Foundation in Basic Research Fund, on-going)
Jan 2024 – Dec 2026 Principal Investigator
Role of STING/IFN-I axis in the pathogenesis of primary Sjogren’s syndrome
(General Research Fund, on-going)
Apr 2024 – Apr 2026 Principal Investigator
Calycosin ameliorates experimental Sjogren’s syndrome via inhibiting effector T cell response.
(Health and Medical Research Fund, on-going)
Sep 2022 – Aug 2024 Principal Investigator
Targeting peroxisome proliferator-activated receptors in the treatment of Sjögren’s syndrome
(Health and Medical Research Fund, 19201121, on-going)
Jan 2022 – Dec 2024 Principal Investigator
Role of Caveolin-1 in regulating T cell responses in primary Sjogren’s syndrome
(General Research Fund, 17116521, on-going)
Jan 2021 – Dec 2023 Principal Investigator
Novel Therapeutic Strategy for Sjogren’s Syndrome: Targeting Myeloid-Derived Suppressor Cells
(General Research Fund, No. 27111820), on-going
Apr 2020 – Apr 2021 Principal Investigator
Heat-cooling Chinese herbs in treating chronic hepatitis B patients comparing with antiviral therapy: A systematic review and network meta-analysis (Health and Medical Research Fund, 17181101, completed)
Jan 2014 – Dec 2016 Principal Investigator
Regulation of experimental Sjögren’s syndrome by Th17 cells
(National Natural Science Foundation of China, 31300739, completed)

Research Awards

2024 Excellence in Leukocyte Biology, Society of Leukocyte Biology
2024 Belt and Road International Undergraduate Forum for Basic Innovative Experiment Design in Medical Sciences, Silver Prize, China Ministry of Education
2023 Early Career Faculty Grant, American Association of Immunologists
2022 National Chinese Medicine Young Investigator Award, China Ministry of Education
2022 Society for Leukocyte Biology Image Contest
2021 Gold medal, QS Reimagine Education Award
2021 Best Oral Presentation, Innovating Drug Immunology Summit
2019 Young Investigator Award, the Hong Kong Society for Immunology
2018 Best Poster Presentation Award, the Hong Kong Society for Immunology
2017 Chinese Medical Science and Technology Awards (201702008)
2016 Best Poster Presentation Award, the Hong Kong Society for Immunology
2016 Beijing Science and Technology Award (2015 醫-2-006)
2015 Outstanding Presentation of Young Investigator, Hong Kong-France Symposium on Transplantation & Cancer Immunology, Institut National de la Santé et de la Recherche Médicale (Inserm), France, and HKU
2014 Croucher Summer Course Scholarship in Immunology
2014 Best Oral Presentation Award, the Hong Kong Society of Flow Cytometry
2014 Best Poster Presentation Award, the Hong Kong Society for Immunology
2013 Honor of Individual Award of Shenzhen Virtual University Park for National Research Project

Editorial Board Member

  • 1. International Journal of Molecular Sciences, Guest Editor
  • 2. Journal of Leukocyte Biology, Section Editor
  • 3. Immunology Letters, Review Editor
  • 4. Frontiers of Pharmacology, Review Editor
  • 5. Frontiers of Immunology, Guest Editor
SELECTED PUBLICATIONS

Selected Publications

  1. Chen Y, Yu S, Li H, Yan H, Xie J, Tang Y, Cheng H, Lin X*. STING/Type I Interferon axis drives interplay between marginal zone B cell and T follicular helper cell in Sjogren’s disease. Cellular & Molecular Immunology 2025, 22, 1444–1458. (IF: 19.8, Q1, 7/246 in Immunology)
  2. Yu S, Wu M, Li H, Chen Y, Xie J, Xu X, Ma D, Feng Y, Shen J*, Lin X*. Calycosin synergizes with methotrexate in the treatment of Sjögren’s disease by targeting BATF in T follicular helper cells, Acta Pharmacologica Sinica. 2025, 46(7):1990-2005. (IF:8.4, Q1, 8/286 in Pharmacology)
  3. Yu S, Wu M, Zeng W, Fu W, Chen Y, Xie J, Li H, Feng Y*, Shen J*, Lin X*.  Caveolin-1/PPARα axis suppresses T follicular helper cell response in primary Sjögren’s disease. Cell Reports, 2025; 44: 116156. (IF:6.9, Q1, 16/336 in Biochemistry, Genetics and Molecular Biology)
  4. Yu S, Lin X*. Humanized mouse models for Sjogren’s disease. Current Protocols. (DOI: 10.1002/cpz1.70178) (IF: 2.05, Q1. 2/43 in Medical Laboratory Technology)
  5. Liu Q, Zeng Y, Xing X, Huang B, Feng R, Wang Y, Wang N, Zhang X, Li Y, Su L, Jacob A, Ambrus JL Jr, Shen L, Suresh L, Yu D, Lin X, He J*. Evaluating the therapeutic potential of tofacitinib in Sjogren's disease: a comprehensive clinical and immunological assessment. Rheumatology (Oxford). 2025, 26:keaf173. (IF: 5.0, Q1, 8/76 in Rheumatology)
  6. Qi X, Zhao D, Wang N, Han Y, Huang B, Feng R, Jin Y, Wang R, Lin X, He J*. B lymphocyte subset-based stratification in primary Sjogren's syndrome: implications for lymphoma risk and personalized treatment. Clin Rheumatol. 2025 ;44(6):2403-2412. (IF: 2.8, Q2, 26/76 in Rheumatology)
  7. Yan H, He J, Lin X*. Heterogeneity of regulatory B cells in autoimmune diseases: implications for immune equilibrium and therapeutic strategies, Immunotherapy Advances, 2025, 8;5(1):ltaf020 (IF: 4.9, Q1, 50/246 in Immunology)
  8. Liu Q, Zeng Y, Xing X, Huang B, Feng R, Wang Y, Wang N, Zhang X, Li Y, Su L, Jacob A, Ambrus JL Jr, Shen L, Suresh L, Lin X, He J*. Evaluating the therapeutic potential of tofacitinib in Sjögren's disease: a comprehensive clinical and immunological assessment. Rheumatology. 2025, 26:keaf173. (IF: 2.8, Q2, 24/58 in Rheumatology)
  9. Ma D, Feng Y*, Lin X*. Immune and Non-Immune Mediators in the Fibrosis Pathogenesis of Salivary Gland in Sjogren's Syndrome. Frontiers in Immunology. 2024,14(15):1421436 (IF: 5.9, Q1, 37/246 in Immunology)
  10. Du Q, Liang R, Wu M, Yang M, Xie Y, Liu Q, Tang K, Lin X, Yuan S, Shen J*. Alisol B 23-acetate broadly inhibits coronavirus through blocking virus entry and suppresses proinflammatory T cells responses for the treatment of COVID-19. Journal of Advanced Research. 2024;62:273-290. (IF: 13.0, Q1, 9/213 in Multidisciplinary)
  11. Yu S, Xie J, Li H, Chen Y, Tang Y, Lin X*. Therapeutic potential of interleukin-17 neutralization in a novel humanized mouse model of Sjogren's disease. Pharmacological Research, 2024, 29:210:107524. (IF:10.5, Q1, 16/752 in Pharmacology, Toxicology and Pharmaceutics)
  12. Yu S#, Zhou X#, Liu R, Xu X, Ma D, Feng Y, Lin X*. Immunomodulatory Effects of Yu-Ping-Feng Formula on Primary Sjogren's Syndrome: Interrogating the T Cell Response. Journal of Leukocyte Biology. 2025; 117(2):qiae155. (Issue Cover, Editorial Highlight, IF: 3.1, Q1, 55/233 in Immunology and Allergy)
  13. Wu M#, Yu S#, Yan S, Wu M, Zhang L, Chen S, Shi D, Liu S, Fan Y, Lin X*, Shen J*. Peroxynitrite reduces Treg cell expansion and function by mediating IL-2R nitration and aggravates multiple sclerosis pathogenesis. Redox Biology.  2024;75:103240. (IF:11.9, Q1, 2/123 in Clinical Biochemistry)
  14. Li WQ, Liu SN, Yang SC, Lin X*, Zhang ZJ*. Nitrous oxide exerts rewarding effect via regulating D1 receptor and BDNF pathway in ventral tegmental area-nucleus accumbens dopamine circuit. Translational Psychiatry. 2025; 15(1):34. (IF:6.2, Q1, 4/56 in Biological Psychiatry)
  15. Mauro D, Lin X, Pontarini E, Wehr P, Guggino G, Tang Y, Deng C, Gandolfo S, Xiao F, Rui K, Huang E, Tian J, Raimondo S, Rischmueller M, Boroky J, Downie-Doyle S, Nel H, Baz-Morelli A, Hsu A, Maraskovsky E, Barr A, Hemon P, Chatzis L, Boschetti CE, Colella G, Alessandro R, Rizzo A, Pers JO, Bombardieri M, Thomas R, Lu L*, Ciccia F*. CD8+ tissue-resident memory T cells are expanded in primary Sjogren's disease and can be therapeutically targeted by CD103 blockade. Annals of the Rheumatic Diseases. 2024; 83(10):1345-1357. (IF:20.6, Q1, 2/58 in Rheumatology)
  16. Chen Y, Xie J, Wu M, Yu S, Shen J*, Lin X*. Ginseng-Epimedii formula ameliorated experimental Sjogren's syndrome via reducing IL-6 production. Journal of Functional Foods. 2024; 116:106198. (IF:4.0, Q1, 78/416 in Food Sciences)
  17. Wang X, Lin X, Su Y, Wang H*. Systematic review with meta-analysis: Efficacy and safety of biological treatment on salivary gland function in primary Sjögren's syndrome. Frontiers in Pharmacology. 2023 Feb 14;14:1093924. (IF: 4.8, Q1, 40/286 in Pharmacology)
  18. Wei Y#, Peng N#, Deng C, Zhao F, Tian J, Tang Y, Yu S, Chen Y, Xue Y, Xiao F, Zhou Y, Li X, Zou H, Rui K*, Lin X*, Lu L*. Aryl hydrocarbon receptor activation drives polymorphonuclear myeloid-derived suppressor cell response and efficiently attenuates experimental Sjogren’s Syndrome. Cellular & Molecular Immunology. 2022, 19, 1361–1372. (IF:19.8, Q1, 7/246 in Immunology)
  19. Zeng W #; Zhou X#; Yu S.; Liu R.; Quek C.; Yu H.; Tay R.; Lin X*; Feng Y*. The Future of Targeted Treatment of Primary Sjögren’s Syndrome: A Focus on Extra-Glandular Pathology. International Journal of Molecular Sciences. 2022, 23, 14135. (IF: 4.9, Q1, 280/2524 in Medicine)
  20. Wu M#, Yu S#, Chen Y, Meng W, Chen H, He J, Shen J*, Lin X*. Acteoside promotes B cell-derived IL-10 production and ameliorates autoimmunity. Journal of Leukocyte Biology (DOI: 10.1002/JLB.3MA0422-510R, Impact factor: 3.2)  
  21. Cao T, Liu L, To KK, Lim CY, Zhou R, Ming Y, Kwan KY, Yu S, Chan CY, Zhou B, Huang H, Mo Y, Du Z, Gong R, Yat LT, Hung IF, Tam AR, To WK, Leung WS, Chik TS, Tsang OT, Lin X, Song YQ, Yuen KY, Chen Z*. Mitochondrial regulation of acute extrafollicular B-cell responses to COVID-19 severity. Clinical and Translational Medicine. 2022;12(9):e1025. (IF: 6.8, Q1, 85/2524 in Medicine)
  22. Wang X, Lin X, Zheng Z, Lu B, Wang J, Tan AH, Zhao M, Loh JT, Ng SW, Chen Q, Xiao F, Huang E1, Ko KH, Huang Z, Li J, Kok KH, Lu G, Liu X, Lam KP, Liu W, Zhang Y, Yuen KY, Mak TW, Lu L. Host- derived lipids orchestrate pulmonary γδ T cell response to provide early protection against influenza virus infection. Nature Communications. 2021, 12: 1914. (IF: 15.7, Q1, 11/336 in Biochemistry, Genetics and Molecular Biology)
  23. Yu H, Wu W, Lin X and Feng Y. Polysaccharide-Based Nanomaterials for Ocular Drug Delivery: A Perspective. Frontiers in Bioengineering and Biotechnology. 2020, 8:601246. (Impact factor: 6.06)
  24. Lin X, Wang X, Xiao F, Ma K, Liu L, Xu D, Wang F, Shi X, Zhao Y, Liu D, Lu L. IL-10-producing regulatory B cells restrain the T follicular helper cell response in primary Sjögren’s syndrome. Cellular & Molecular Immunology. 2019, 16: 921-931. (IF:19.8, Q1, 7/246 in Immunology)
  25. Wang X, Ye C, Lin X, Ma K, Xiao F, Li L, Lu L. New insights into the significance of the BCR repertoire in B-1 cell development and function. Cellular & Molecular Immunology. 2019, 16(9): 772-773. (IF:19.8, Q1, 7/246 in Immunology)
  26. Ma K, Wang X, Shi X, Lin X, Xiao F, Ma X, Liu D, Lu L. The expanding functional diversity of plasma cells in immunity and inflammation. Cellular & Molecular Immunology. 2019, doi: 10.1038/s41423-019-0308-z (IF:19.8, Q1, 7/246 in Immunology)
  27. Tian J, Rui K, Hong Y, Wang X, Xiao F, Lin X, Ma J, Guo H, Xu H, Ma K, Xu D, Liu D, Zhao Y, Lu L, Wang S. Increased GITRL Impairs the Function of Myeloid-Derived Suppressor Cells and Exacerbates Primary Sjögren Syndrome. The Journal of Immunology. 2019, 15;202(6):1693-1703. (Impact factor: 5.42)
  28. Guggino G*, Lin X* (co-first author), Rizzo A, Xiao F, Saieva L, Liberto D, Candore G, Ruscitti P, Cipriani P, Giacomelli R, Dieli F, Alessandro R, Triolo G, #Lu L, #Francesco C. Interleukin-25 Axis Is Involved in the Pathogenesis of Human Primary and Experimental Murine Sjogren's Syndrome. Arthritis & Rheumatology. 2018, 70(8):1265-1275. (IF:10.9, Q1, 16/246 in Immunology)
  29. Ma K, Li J, Wang X, Lin X, Du W, Yang X, Mou F, Fang Y, Zhao Y, Hong X, Chan KW, Zhang X, Liu D, Sun L, Lu L. TLR4(+)CXCR4(+) plasma cells drive nephritis development in systemic lupus erythematosus. Annals of the Rheumatic Diseases. 2018, 77:1498-1506. (IF:20.6, Q1, 2/58 in Rheumatology)
  30. Fu W, Liu X, Lin X, Feng H, Sun L, Li S, Chen H, Tang H, Lu L, Jin W, Dong C. Deficiency in T follicular regulatory cells promotes autoimmunity. Journal of Experimental Medicine. 2018; 215(3):815-825. (IF:10.6, Q1, 8/246 in Immunology)
  31. Rui K*, Lin X* (co-first author), Tian J, Wang X, Sun L, Hong X, Liu D, Wang S, Lu L. Ecto-mesenchymal stem cells: a new player for immune regulation and cell therapy. Cellular & Molecular Immunology. 2018, 15(1):82-84. (Impact factor: 22.09)
  32. Xiao F, Lin X, Tian J, Wang X, Chen Q, Rui K, Ma J, Wang S, Wang Q, Wang X, Liu D, Sun L, Lu L. Proteasome Inhibition Suppresses Th17 cell Generation and Ameliorates Autoimmune Development in Sjögren’s Syndrome. Cellular & Molecular Immunology. 2017, 14: 924–934. (IF:19.8, Q1, 7/246 in Immunology)
  33. Lin X, Rui K, Deng J, Tian J, Wang X, Wang S, Ko KH, Jiao Z, Chan VS, Lau CS, Cao X, Lu L. Th17 cells play a critical role in the development of experimental Sjögren's syndrome. Annals of the Rheumatic Diseases. 2015, 74(6):1302-10. (IF:20.6, Q1, 2/58 in Rheumatology)
  34. Rui K, Zhang Z, Tian J, Lin X, Wang X, Ma J, Tang X, Xu H, Lu L, Wang S. Olfactory ecto-mesenchymal stem cells possess immunoregulatory function and suppress autoimmune arthritis. Cellular & Molecular Immunology, 2016, 13(3):401-8. (IF:19.8, Q1, 7/246 in Immunology)
  35. Lin X, Liu J, Chung W, Sze SC, Li H, Lao L, Zhang Y. Polysaccharides of Dendrobium officinale Induce Aquaporin 5 Translocation by Activating M3 Muscarinic Receptors. Planta medica. 2015, 81(2):130-137. (Impact factor: 3.00)
  36. Lin X, Tian J, Rui K, Ma KY, Ko KH, Wang S, Lu L. The role of T helper 17 cell subsets in Sjögren's syndrome: similarities and differences between mouse model and humans. Annals of the Rheumatic Diseases.2014, 73(7):e43. (IF:20.6, Q1, 2/58 in Rheumatology)
  37. Lin X, Shaw PC, Sze CW, Tong Y, Zhang YB. Polysaccharides of Dendrobium Officinale inhibit TNF-α induced apoptosis in A-253 cell line. Inflammation Research. 2013 63 (3): 313-24 (IF:5.4, Q1, 60/246 in Immunology)
  38. Lin X, Shaw PC, Sze SC, Tong Y, Zhang Y. Dendrobium officinale polysaccharides ameliorate the abnormality of aquaporin 5, pro-inflammatory cytokines and inhibit apoptosis in the experimental Sjögren's syndrome mice. International Immunopharmacology. 2011, 11 (12): 2025-32. (IF:4.7, Q1, 49/333 in Pharmacology)
  39. Lin X, Song JX, Shaw PC, Ng TB, Sze CW, Tong Y, Lee KF, Zhang KY. An autoimmunized mouse model recapitulates key features in the pathogenesis of Sjögren's syndrome. International Immunology. 2011 23 (10): 613-624. (IF:3.2, Q1, 45/246 in Immunology)
  40. Song JX, Lin X, Wong RNS, Sze SCW, Tong Y, Shaw PC, Zhang YB. Protective effects of dibenzocyclooctadiene lignans from Schisandra chinensis against beta‐amyloid and homocysteine neurotoxicity in PC12 cells. Phytotherapy Research. 2011, 25 (3), 435-443 (IF: 6.3, Q1, 38/333 in Pharmacology)

Other Publications

  1. Weifeng Wu, Xiao R Huang, Yongke You, Liang Xue, Xiao-Jing Wang, Xiaoming Meng, Xiang Lin, Jiangang Shen, Xueqing Yu, Hui-Yao Lan, Haiyong Chen. Latent TGF-b1 protects against diabetic kidney disease via Arkadia/Smad7 signaling. Int J Biol Sci 2021, 19;17(13):3583-3594. (Impact factor: 10.75; Q1)
  2. Fraide A Ganotice, Kelvin Kai Hin Fan, Zoe Lai Han Ng, Francis Hang Sang Tsoi, Abraham Ka Chung Wai, Alan Worsley, Xiang Lin, George L Tipoe. The short version of students' perceptions of interprofessional clinical education-revised (SPICE-R3): a confirmatory factor analysis. Journal of Interprofessional Care (Impact factor: 2.66; Q2)
  3. Shayi Wu*, Miao Chen*, Jiao Huang, Feifei Zhang, Zhaojie Lv, Yongxu Jia,2 Yu-Zhu Cui, Liang-Zhan Sun, Ying Wang, , Ying Tang, Krista R. Verhoeft, Yan Li, Yanru Qin, Xiang Lin, Xin-Yuan Guan#, Ka-On Lam#. ORAI2 Promotes Gastric Cancer Tumorigenicity and Metastasis Through PI3K/Akt Signaling and MAPK-dependent Focal Adhesion Disassembly. Cancer Research. 2020 DOI: 10.1158/0008-5472.CAN-20-0049. (Impact factor: 13.31 Q1)
  4. Zhao J Lyu, Ying Wang, Jin L Huang, Miao Chen, Sha Y Wu, Qian Yan, Yu Zhang, Ying Tang, Chen Jiang, Lei Li, Yi Z Jia, Yu C Liu, Hong B Mei, Feng Wang, Ren H Li, Ya C Chen, Xiang Lin, Zhi M Cai, Xin Y Guan. Recurrent ZNF83-E293V Mutation Promotes Bladder Cancer Progression through the NF-κB Pathway via Transcriptional Dysregulation of S100A8. Molecular Therapy. 2020 S1525-0016(20)30461-5. (Impact factor: 12.91; Q1)
  5. Chu H, Zhou J, Wong BH, Li C, Cheng ZS, Lin X, Poon VK, Sun T, Lau CC, Chan JF, To KK, Chan KH, Lu L, Zheng BJ, Yuen KY. Productive replication of Middle East respiratory syndrome coronavirus in monocyte-derived dendritic cells modulates innate immune response. Virology. 2014, 454-455:197-205. (Impact factor: 3.51; Q2)

CONFERENCE PAPERS

  1. Yu S, Xie J, Lin X*. A novel humanized mouse model of Sjogren’s disease. 19th International Congress of Immunology, Aug 17-22, 2025, Vienna, Austria. Proceeding/Conference: Frontiers in Immunology.
  2. Yu S, Wu M, Shen J, Lin X*. Targeting T follicular helper cells in the Sjogren’s disease by calycosin. 2025 European Congress of Rheumatology, Jun 11-14, 2025, Barcelona, Spain. Proceeding/Conference: Annals of the Rheumatic Diseases. 2025; 84: 2074.
  3. Yu S, Wu M, Shen J, Lin X*. Caveolin-1/PPARα axis restrains pathogenic T follicular helper cell response in primary Sjögren’s syndrome. 7th European Congress of Immunology, Sep 1-4, 2024, Dublin, Ireland. Proceeding/Conference:European Journal of Immunology. 2024; 54: 2470200.
  4. Lin X. Tryptophan diet promotes myeloid-derived suppressor cell response via aryl hydrocarbon receptor in Sjogren’s syndrome. 2023. May, Washington, USA. Proceeding/Conference: Journal of Immunology. 2023; 210 (1_Supplement): 165.04.
  5. Blocking of CD103+ tissue resident memory t cells (TRM) as a therapeutic strategy in Sjogren’s syndrome. Proceeding/Conference: Annals of the Rheumatic Diseases
  6. Novel function of IL-17E in the autoimmune pathogenesis of experimental Sjogren´s syndrome Proceeding/Conference: European Journal of Immunology
  7. Polysaccharides from dendrobium officinale ameliorate murine Sjögren's syndrome development via modulating immune responses. Proceeding/Conference:7th Federation of Immunological Societies of Asia-Oceania Congress (FIMSA 2018)
  8. A Critical Role of Th17 Cells in the Development of Murine Sjogeren’s Syndrome. Proceeding/Conference: Journal of Immunology

BOOK CHAPTER

  1. Xie J, Lin X*. Traditional Chinese Medicine in Immunology. In Clinical Immunology (Textbook, in Chinese). Chapter 21. China, Higher Education Press Limited. Peer Review (Accepted).
  2. Xu X, Lin X*. Role of Regulatory T cells in Pathogenesis and Therapeutics of Primary Sjogren's Syndrome, Regulatory T cells and Autoimmune Diseases, 1st Edition. 2024. Academic Publisher. Elsevier. ISBN: 9780443139475. Peer Review.
  3. Yu S, Wu M, Feng Y, Shen J, Lu L and Lin X*. Detection of T follicular helper cells and T follicular regulatory cells in experimental Sjogren's syndrome. Methods in Molecular Biology. Humana Press, New York, 2021. NY 2022:2380:211-224. Peer Review.
  4. Lin X, Wang X, Lu L*. Detection of IL-10 in Murine B Cells: In Vitro and In Vivo Techniques. Methods in Molecular Biology. Humana Press, New York, NY 2021;2270:93-111. Peer Review.
  5. Lin X, Lu L. (2019) Chapter 13: B cell-mediated autoimmune diseases. B Cells in Immunity and Tolerance. Advances in Experimental Medicine and Biology. Springer Nature International Publishing AG. (United States)
  6. Lin X, Deng J, Lu L. (2014) IL-10 Detection in Murine B Cells: Pros and Cons of the Different Techniques. In: Vitale G., Mion F. (eds) Regulatory B Cells. Methods in Molecular Biology. Humana Press, New York, NY
  7. Lin X, Zhang Kalin YB (2009) Chapter 28-30, Basic and Clinical Toxicology of Chinese Medicine. Commercial Press (HK) Ltd. (Chinese).